Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1985 Aug 1;133(3):193–198.

Early-stage Hodgkin's disease: current approaches to treatment.

J J Rusthoven, R MacKenzie
PMCID: PMC1346147  PMID: 3893668

Abstract

Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches. This review highlights the developments in the diagnosis and treatment of the disease that have led to long-term survival rates greater than 90%. Past and present radio-therapy (RT) planning and treatment practices are discussed in the context of both clinical and pathological staging. The role of initial bimodal therapy (RT and chemotherapy [CT]) and the use of CT in patients who suffer relapse after initial treatment with RT alone are reviewed. On the basis of prognostic factors, subgroups of patients for whom bimodal therapy is recommended, including those with a bulky mediastinal mass, have now been identified. Although treatment is highly successful, debilitating consequences of RT and CT, such as infertility, infection and second malignant diseases, remain. Newer treatment regimens may reduce morbidity and have similar or better long-term results with respect to survival and quality of life.

Full text

PDF
193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrieu J. M., Bayle-Weisgerber C., Boiron M., Briere J. F., Clot P., Dana M., Jacquillat C., Katz M., Teillet F. The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial. Eur J Cancer. 1979 Feb;15(2):153–161. doi: 10.1016/0014-2964(79)90055-0. [DOI] [PubMed] [Google Scholar]
  2. Bergsagel D. E., Alison R. E., Bean H. A., Brown T. C., Bush R. S., Clark R. M., Chua T., Dalley D., DeBoer G., Gospodarowicz M. Results of treating Hodgkin's disease without a policy of laparotomy staging. Cancer Treat Rep. 1982 Apr;66(4):717–731. [PubMed] [Google Scholar]
  3. Bonadonna G., Santoro A. ABVD chemotherapy in the treatment of Hodgkin's disease. Cancer Treat Rev. 1982 Mar;9(1):21–35. doi: 10.1016/s0305-7372(82)80003-0. [DOI] [PubMed] [Google Scholar]
  4. Coltman C. A., Jr, Dixon D. O. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup. Cancer Treat Rep. 1982 Apr;66(4):1023–1033. [PubMed] [Google Scholar]
  5. Cooper M. R., Pajak T. F., Gottlieb A. J., Glicksman A. S., Nissen N., Richards F., 2nd, Bloomfield C., Holland J. F. The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease. J Clin Oncol. 1984 Jul;2(7):748–755. doi: 10.1200/JCO.1984.2.7.748. [DOI] [PubMed] [Google Scholar]
  6. Hagemeister F. B., Fuller L. M., Velasquez W. S., Sullivan J. A., North L., Butler J. J., Johnston D. A., Shullenberger C. C. Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP. Cancer Treat Rep. 1982 Apr;66(4):789–798. [PubMed] [Google Scholar]
  7. Hoppe R. T., Coleman C. N., Cox R. S., Rosenberg S. A., Kaplan H. S. The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood. 1982 Mar;59(3):455–465. [PubMed] [Google Scholar]
  8. Jacquillat C., Khayat D., Desprez-Curely J. P., Weil M., Brocheriou C., Auclerc G., Chamseddine N., Bernard J. Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature. Cancer. 1984 Feb 1;53(3):459–462. doi: 10.1002/1097-0142(19840201)53:3<459::aid-cncr2820530315>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  9. Notter D. T., Grossman P. L., Rosenberg S. A., Remington J. S. Infections in patients with Hodgkin's disease: a clinical study of 300 consecutive adult patients. Rev Infect Dis. 1980 Sep-Oct;2(5):761–800. doi: 10.1093/clinids/2.5.761. [DOI] [PubMed] [Google Scholar]
  10. Schomberg P. J., Evans R. G., O'Connell M. J., White W. L., Banks P. M., Ilstrup D. M., Earle J. D. Prognostic significance of mediastinal mass in adult Hodgkin's disease. Cancer. 1984 Jan 15;53(2):324–328. doi: 10.1002/1097-0142(19840115)53:2<324::aid-cncr2820530225>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  11. Sutcliffe S. B., Gospodarowicz M. K., Bergsagel D. E., Bush R. S., Alison R. E., Bean H. A., Brown T. C., Chua T., Clark R. M., Curtis J. E. Prognostic groups for management of localized Hodgkin's disease. J Clin Oncol. 1985 Mar;3(3):393–401. doi: 10.1200/JCO.1985.3.3.393. [DOI] [PubMed] [Google Scholar]
  12. Thar T. L., Million R. R., Hausner R. J., McKetty M. H. Hodgkin's disease, stages I and II: relationship of recurrence to size of disease, radiation dose, and number of sites involved. Cancer. 1979 Mar;43(3):1101–1105. doi: 10.1002/1097-0142(197903)43:3<1101::aid-cncr2820430348>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  13. Timothy A. R., Sutcliffe S. B., Wrigley P. F., Jones A. E. Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy. Int J Radiat Oncol Biol Phys. 1979 Feb;5(2):165–169. doi: 10.1016/0360-3016(79)90715-6. [DOI] [PubMed] [Google Scholar]
  14. Tubiana M., Henry-Amar M., Hayat M., Burgers M., Qasim M., Somers R., Sizoo W., van der Schueren E. The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy. Int J Radiat Oncol Biol Phys. 1984 Feb;10(2):197–210. doi: 10.1016/0360-3016(84)90004-x. [DOI] [PubMed] [Google Scholar]
  15. da Cunha M. F., Meistrich M. L., Fuller L. M., Cundiff J. H., Hagemeister F. B., Velasquez W. S., McLaughlin P., Riggs S. A., Cabanillas F. F., Salvador P. G. Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy. J Clin Oncol. 1984 Jun;2(6):571–577. doi: 10.1200/JCO.1984.2.6.571. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES